RY8 — Rongyu Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual balance sheet for Rongyu Pharmaceuticals, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | AAS | AAS | AAS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 9.79 | 3.08 | 13.8 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 7.08 | 13.5 | 22.7 |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | 18.5 | 18.1 | 38.2 |
| Net Property, Plant And Equipment | 6.77 | 9.01 | 7.36 |
| Net Intangible Assets | |||
| Total Assets | 25.9 | 27.7 | 46.1 |
| Accounts Payable | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 6.33 | 6.05 | 7.19 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 6.33 | 6.05 | 7.19 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 19.6 | 21.7 | 38.9 |
| Total Liabilities & Shareholders' Equity | 25.9 | 27.7 | 46.1 |
| Total Common Shares Outstanding |